Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Journal of Affective Disorders
|
September 12, 2013
Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS)
Saeheon Jang, Sungwon Jung, Chiun Pae, et al.
The Journal of Clinical Psychiatry
|
January 17, 2012
Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials
Enrico Tedeschini, Yeciel Levkovitz, Nadia Iovieno, et al.
The Annals of Pharmacotherapy
|
May 30, 2013
Medical costs and hospitalizations among patients with depression treated with adjunctive atypical antipsychotic therapy: an analysis of health insurance claims data
Rachel Halpern, Anagha Nadkarni, Iftekhar Kalsekar, et al.
The American Journal of Psychiatry
|
March 4, 2003
Psychotic depression and mortality
Meena Vythilingam, Joyce Chen, J Douglas Bremner, et al.
CNS Spectrums
|
October 31, 2013
Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials
Chi-Un Pae, Ashwin A Patkar, Saeheon Jang, et al.
Primary Care Companion to the Journal of Clinical Psychiatry
|
September 12, 2006
The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials
J Craig Nelson, Yili Lu Pritchett, Oleg Martynov, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
February 25, 2005
Duloxetine for the treatment of major depressive disorder in older patients
J Craig Nelson, Madelaine M Wohlreich, Craig H Mallinckrodt, et al.
Journal of Affective Disorders
|
March 5, 2019
Plasma serotonin levels are associated with antidepressant response to SSRIs
Amanda Holck, Owen M Wolkowitz, Sindy H Mellon, et al.
Depression and Anxiety
|
October 12, 2013
Clinical relevance of fatigue as a residual symptom in major depressive disorder
Maurizio Fava, Susan Ball, J Craig Nelson, et al.
The American Journal of Psychiatry
|
July 2, 2003
An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression
Lon S Schneider, J Craig Nelson, Cathryn M Clary, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Journal of Affective Disorders
|
September 12, 2013
Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS)
Saeheon Jang, Sungwon Jung, Chiun Pae, et al.
The Journal of Clinical Psychiatry
|
January 17, 2012
Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials
Enrico Tedeschini, Yeciel Levkovitz, Nadia Iovieno, et al.
The Annals of Pharmacotherapy
|
May 30, 2013
Medical costs and hospitalizations among patients with depression treated with adjunctive atypical antipsychotic therapy: an analysis of health insurance claims data
Rachel Halpern, Anagha Nadkarni, Iftekhar Kalsekar, et al.
The American Journal of Psychiatry
|
March 4, 2003
Psychotic depression and mortality
Meena Vythilingam, Joyce Chen, J Douglas Bremner, et al.
CNS Spectrums
|
October 31, 2013
Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials
Chi-Un Pae, Ashwin A Patkar, Saeheon Jang, et al.
Primary Care Companion to the Journal of Clinical Psychiatry
|
September 12, 2006
The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials
J Craig Nelson, Yili Lu Pritchett, Oleg Martynov, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
February 25, 2005
Duloxetine for the treatment of major depressive disorder in older patients
J Craig Nelson, Madelaine M Wohlreich, Craig H Mallinckrodt, et al.
Journal of Affective Disorders
|
March 5, 2019
Plasma serotonin levels are associated with antidepressant response to SSRIs
Amanda Holck, Owen M Wolkowitz, Sindy H Mellon, et al.
Depression and Anxiety
|
October 12, 2013
Clinical relevance of fatigue as a residual symptom in major depressive disorder
Maurizio Fava, Susan Ball, J Craig Nelson, et al.
The American Journal of Psychiatry
|
July 2, 2003
An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression
Lon S Schneider, J Craig Nelson, Cathryn M Clary, et al.
Page
of 9